Panretin alitretinoin 0: Phase III data; NDA submitted

By WIR Staff | Jul 6, 1998 | 7:00 AM GMT

LGND presented a final analysis of 134 patients from

Read the full 91 word article

How to gain access

Continue reading with a
two-week free trial.